March 24, 2020 / 1:03 PM / 13 days ago

BRIEF-Akers Biosciences Acquires Licenses To Coronavirus Vaccine Candidate From Premas Biotech

March 24 (Reuters) - Akers Biosciences Inc:

* AKERS BIOSCIENCES ACQUIRES LICENSES TO CORONAVIRUS VACCINE CANDIDATE FROM PREMAS BIOTECH

* AKERS BIOSCIENCES INC - ACQUIRING CYSTRON BIOTECH LLC FOR A $1 MILLION UPFRONT PAYMENT, 622,756 SHARES OF COMMON STOCK AND A ROYALTY ON NET SALES.

* AKERS BIOSCIENCES INC - RAPID COMMERCIAL SCALE-UP PROCESSES IN PLACE WITH PREMAS BASED ON GENETICALLY ENGINEERED YEAST PLATFORM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below